|
Volumn 121, Issue 10, 2010, Pages 1188-1199
|
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIN BINDING PROTEIN;
ADENOSINE;
ANTITHROMBOCYTIC AGENT;
CELL ADHESION MOLECULE;
CLOPIDOGREL;
DRUG DERIVATIVE;
PHOSPHOPROTEIN;
PURINERGIC P2 RECEPTOR;
PURINERGIC P2Y12 RECEPTOR;
TICAGRELOR;
TICLOPIDINE;
VASODILATOR STIMULATED PHOSPHOPROTEIN;
VASODILATOR-STIMULATED PHOSPHOPROTEIN;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PHOSPHORYLATION;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTE AGGREGATION;
ADENOSINE;
AGED;
CELL ADHESION MOLECULES;
CORONARY ARTERY DISEASE;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
MALE;
MICROFILAMENT PROTEINS;
MIDDLE AGED;
PHOSPHOPROTEINS;
PHOSPHORYLATION;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
RECEPTORS, PURINERGIC P2;
TICLOPIDINE;
|
EID: 77950508416
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.109.919456 Document Type: Article |
Times cited : (430)
|
References (0)
|